| Good News for Bayer, J&J - Zacks.com |
|
|
Zacks.com Recently, the Cardiovascular and Renal Drugs Advisory Committee of the US Food and Drug Administration (FDA) issued a positive opinion and recommended the US approval of Bayer's (BAYRY - Analyst Report) blood-thinner Xarelto (rivaroxaban) for an ... Bayer Confident in Results of ROCKET AF Study to Be Reviewed by the FDA |